| Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects (NCT01010542) | Pfizer | 2009-12-01 |
| A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients (NCT00998764) | Pfizer | 2009-12-01 |
| Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH) (NCT01445873) | Pfizer | 2009-12-01 |
| A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients (NCT00927823) | Pfizer | 2009-12-01 |
| A Global Active Surveillance for Community Acquired Pneumonia (NCT00929721) | Pfizer | 2009-12-01 |
| Prevenar (PCV-7) Post-Licensure Safety Study In Russia (NCT01207583) | Pfizer | 2009-12-01 |
| Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis (NCT01008852) | Pfizer | 2009-12-01 |
| Multiple Oral Dose Safety, Tolerability And Pharmacokinetic Study Of PF-04287881 In Healthy Adult Subjects (NCT01026545) | Pfizer | 2009-12-01 |
| Study Evaluating Persistence Of Antibody Response Elicited By 13vPnC In Healthy Adults Previously Vaccinated (NCT01025336) | Pfizer | 2009-12-01 |
| Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected (NCT01030640) | Pfizer | 2009-12-01 |
| A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Patch Applied To The Skin (NCT01013454) | Pfizer | 2009-12-01 |
| A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients (NCT00996918) | Pfizer | 2009-12-01 |
| Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients (NCT00914459) | Pfizer | 2009-12-01 |
| A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease (NCT01028911) | Pfizer | 2009-12-01 |
| Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty (NCT01038297) | Pfizer | 2009-12-01 |
| First In Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Adult Volunteers (NCT01011296) | Pfizer | 2009-12-01 |
| A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections (NCT00994890) | Pfizer | 2009-11-17 |
| Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections (NCT01015014) | Pfizer | 2009-11-05 |
| Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease (NCT00955409) | Pfizer | 2009-11-05 |
| Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis (NCT01029405) | Pfizer | 2009-11-01 |
| A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy (NCT01006122) | Pfizer | 2009-11-01 |
| A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis (NCT00976599) | Pfizer | 2009-11-01 |
| Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction (NCT01033669) | Pfizer | 2009-11-01 |
| Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects (NCT00987337) | Pfizer | 2009-11-01 |
| A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function (NCT00969813) | Pfizer | 2009-11-01 |
| Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS (NCT00963235) | Pfizer | 2009-11-01 |
| Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease (NCT00918580) | Pfizer | 2009-11-01 |
| Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin Release (NCT00988949) | Pfizer | 2009-11-01 |
| A Pharmacokinetic (PK) Study Of PF-00299804 And Dextromethorphan In Healthy Volunteers (NCT00999817) | Pfizer | 2009-11-01 |
| Group Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-04531083 In Healthy Subjects (NCT01012310) | Pfizer | 2009-11-01 |
| Toviaz Post Marketing Surveillance Study (NCT00879398) | Pfizer | 2009-11-01 |
| A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia (NCT00977522) | Pfizer | 2009-11-01 |
| A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult Subjects (NCT00991159) | Pfizer | 2009-11-01 |
| A Study To Investigate Whether PF-04457845 Is Effective In Treating Pain, Is Safe And Tolerable In Patients With Osteoarthritis Of The Knee (NCT00981357) | Pfizer | 2009-11-01 |
| A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03526299 In Healthy Adult Volunteers (NCT00990756) | Pfizer | 2009-11-01 |
| Figitumumab Combined With Pegvisomant For Advanced Solid Tumors (NCT00976508) | Pfizer | 2009-11-01 |
| A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers (NCT01002625) | Pfizer | 2009-11-01 |
| Muscle Malonyl Coa Biomarker Assay Development (NCT01003444) | Pfizer | 2009-11-01 |
| A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery (NCT00889720) | Pfizer | 2009-11-01 |
| A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers (NCT00992342) | Pfizer | 2009-11-01 |
| Tanezumab In Osteoarthritis Of The Hip Or Knee (NCT00985621) | Pfizer | 2009-10-30 |
| Open Label Extension In Cancer Patients (NCT00830180) | Pfizer | 2009-10-29 |
| BeneFIX Drug Use Results Survey [All-Case Surveillance] (NCT01154231) | Pfizer | 2009-10-29 |
| A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease (NCT00988598) | Pfizer | 2009-10-26 |
| A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis (NCT00938587) | Pfizer | 2009-10-07 |
| Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers (NCT00991016) | Pfizer | 2009-10-01 |
| Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors (NCT00960440) | Pfizer | 2009-10-01 |
| Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel. (NCT01421303) | Pfizer | 2009-10-01 |
| A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) (NCT00988624) | Pfizer | 2009-10-01 |
| Genotropin Study Assessing Use of Injection Pen (NCT00965484) | Pfizer | 2009-10-01 |
| A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers (NCT00990015) | Pfizer | 2009-10-01 |
| A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients (NCT00971893) | Pfizer | 2009-10-01 |
| Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid (NCT00987220) | Pfizer | 2009-10-01 |
| A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response. (NCT01064726) | Pfizer | 2009-10-01 |
| A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin (NCT00990613) | Pfizer | 2009-10-01 |
| Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan) (NCT00998309) | Pfizer | 2009-10-01 |
| A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth (NCT00989391) | Pfizer | 2009-10-01 |
| A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users (NCT00975481) | Pfizer | 2009-10-01 |
| Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy (NCT00935012) | Pfizer | 2009-09-30 |
| Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy (NCT00974311) | Pfizer | 2009-09-30 |
| A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease (NCT00930059) | Pfizer | 2009-09-10 |
| Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin (NCT00970593) | Pfizer | 2009-09-02 |
| Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery (NCT00827931) | Pfizer | 2009-09-01 |
| Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis (NCT00913458) | Pfizer | 2009-09-01 |
| Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder (NCT01221935) | Pfizer | 2009-09-01 |
| A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers (NCT00971802) | Pfizer | 2009-09-01 |
| To Test The Relative Bioavailability Of PF-04191834 When Dosed As An Immediate Release Tablet Compared With Solution Following Single And Multiple Dosing (NCT01064804) | Pfizer | 2009-09-01 |
| Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia (NCT00886743) | Pfizer | 2009-09-01 |
| Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects (NCT00981968) | Pfizer | 2009-09-01 |
| An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease (NCT00939783) | Pfizer | 2009-09-01 |
| Study To Estimate The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers (NCT00977015) | Pfizer | 2009-09-01 |
| A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography) (NCT00939887) | Pfizer | 2009-09-01 |
| A Study to Investigate the Effect of ICA-105665 in Photosensitive Epilepsy Patients (NCT00979004) | Pfizer | 2009-09-01 |
| A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease (NCT00912288) | Pfizer | 2009-09-01 |
| A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers (NCT01002963) | Pfizer | 2009-09-01 |
| A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma (NCT00982657) | Pfizer | 2009-09-01 |
| This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors (NCT00932126) | Pfizer | 2009-09-01 |
| Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis (NCT00962741) | Pfizer | 2009-09-01 |
| Study Evaluating The Safety And Tolerability Of Administration Of Single Oral Doses Of SAM-760 To Healthy Subjects (NCT00948662) | Pfizer | 2009-09-01 |
| A Multiple Dose Study To Determine Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Healthy Adult Subjects (NCT00956956) | Pfizer | 2009-09-01 |
| A Midazolam Drug Interaction Study With PF-04171327 (NCT00987038) | Pfizer | 2009-09-01 |
| Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer (NCT00959946) | Pfizer | 2009-09-01 |
| A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients (NCT00929981) | Pfizer | 2009-09-01 |
| A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors (NCT00915278) | Pfizer | 2009-09-01 |
| A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder (NCT00928070) | Pfizer | 2009-09-01 |
| An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene (NCT00932893) | Pfizer | 2009-09-01 |
| Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer (NCT00920816) | Pfizer | 2009-08-25 |
| Long Term Safety Study of Tanezumab in Chronic Low Back Pain (NCT00924664) | Pfizer | 2009-08-20 |
| Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip (NCT00864097) | Pfizer | 2009-08-11 |
| A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease (NCT00945672) | Pfizer | 2009-08-06 |
| Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis (NCT00925002) | Pfizer | 2009-08-05 |
| Axitinib Pharmacokinetics in Chinese Healthy Volunteers (NCT00919204) | Pfizer | 2009-08-01 |
| An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System (NCT00806351) | Pfizer | 2009-08-01 |
| Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment (NCT00929357) | Pfizer | 2009-08-01 |
| A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency (NCT00911937) | Pfizer | 2009-08-01 |
| Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer (NCT00835978) | Pfizer | 2009-08-01 |
| Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients (NCT00952380) | Pfizer | 2009-08-01 |
| Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease (NCT00959192) | Pfizer | 2009-08-01 |
| Effects of ICA-105665 Using the Intradermal Capsaicin and Ultraviolet B (UV-B) Models in Healthy Male Subjects (NCT00962663) | Pfizer | 2009-08-01 |
| A Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03049423 In Healthy Adult Volunteers And Healthy Older Volunteers (NCT01161069) | Pfizer | 2009-08-01 |